203 related articles for article (PubMed ID: 30465437)
21. Doxorubicin-modified magnetic nanoparticles as a drug delivery system for magnetic resonance imaging-monitoring magnet-enhancing tumor chemotherapy.
Liang PC; Chen YC; Chiang CF; Mo LR; Wei SY; Hsieh WY; Lin WL
Int J Nanomedicine; 2016; 11():2021-37. PubMed ID: 27274233
[TBL] [Abstract][Full Text] [Related]
22.
Mortezazadeh T; Gholibegloo E; Khoobi M; Alam NR; Haghgoo S; Mesbahi A
J Drug Target; 2020 Jun; 28(5):533-546. PubMed ID: 31842616
[No Abstract] [Full Text] [Related]
23. NIR-Light-Triggered Anticancer Strategy for Dual-Modality Imaging-Guided Combination Therapy via a Bioinspired Hybrid PLGA Nanoplatform.
Shen X; Li T; Chen Z; Xie X; Zhang H; Feng Y; Li S; Qin X; Yang H; Wu C; Zheng C; Zhu J; You F; Liu Y
Mol Pharm; 2019 Mar; 16(3):1367-1384. PubMed ID: 30776896
[TBL] [Abstract][Full Text] [Related]
24. Development of a multifunctional system based on CoFe
Arkaban H; Khajeh Ebrahimi A; Yarahmadi A; Zarrintaj P; Barani M
Nanotechnology; 2021 May; 32(30):. PubMed ID: 33857938
[TBL] [Abstract][Full Text] [Related]
25. A superparamagnetic polymersome with extremely high T
Liu Q; Song L; Chen S; Gao J; Zhao P; Du J
Biomaterials; 2017 Jan; 114():23-33. PubMed ID: 27837682
[TBL] [Abstract][Full Text] [Related]
26. Novel doxorubicin / folate-targeted trans-ferulic acid-loaded PLGA nanoparticles combination: In-vivo superiority over standard chemotherapeutic regimen for breast cancer treatment.
Helmy SA; El-Mofty S; El Gayar AM; El-Sherbiny IM; El-Far YM
Biomed Pharmacother; 2022 Jan; 145():112376. PubMed ID: 34749055
[TBL] [Abstract][Full Text] [Related]
27. Nanosonosensitizers for Highly Efficient Sonodynamic Cancer Theranostics.
Huang J; Liu F; Han X; Zhang L; Hu Z; Jiang Q; Wang Z; Ran H; Wang D; Li P
Theranostics; 2018; 8(22):6178-6194. PubMed ID: 30613291
[No Abstract] [Full Text] [Related]
28. IGF1 Receptor Targeted Theranostic Nanoparticles for Targeted and Image-Guided Therapy of Pancreatic Cancer.
Zhou H; Qian W; Uckun FM; Wang L; Wang YA; Chen H; Kooby D; Yu Q; Lipowska M; Staley CA; Mao H; Yang L
ACS Nano; 2015 Aug; 9(8):7976-91. PubMed ID: 26242412
[TBL] [Abstract][Full Text] [Related]
29. Co-encapsulation of superparamagnetic nanoparticles and doxorubicin in PLGA nanocarriers: Development, characterization and in vitro antitumor efficacy in glioma cells.
Luque-Michel E; Sebastian V; Larrea A; Marquina C; Blanco-Prieto MJ
Eur J Pharm Biopharm; 2019 Dec; 145():65-75. PubMed ID: 31628997
[TBL] [Abstract][Full Text] [Related]
30. Study and evaluation of nucleolin-targeted delivery of magnetic PLGA-PEG nanospheres loaded with doxorubicin to C6 glioma cells compared with low nucleolin-expressing L929 cells.
Mosafer J; Teymouri M; Abnous K; Tafaghodi M; Ramezani M
Mater Sci Eng C Mater Biol Appl; 2017 Mar; 72():123-133. PubMed ID: 28024568
[TBL] [Abstract][Full Text] [Related]
31. Design, preparation, and in vitro characterization of a trimodally-targeted nanomagnetic onco-theranostic system for cancer diagnosis and therapy.
Zarrin A; Sadighian S; Rostamizadeh K; Firuzi O; Hamidi M; Mohammadi-Samani S; Miri R
Int J Pharm; 2016 Mar; 500(1-2):62-76. PubMed ID: 26721723
[TBL] [Abstract][Full Text] [Related]
32. Folate-receptor-targeted laser-activable poly(lactide-
Liu F; Chen Y; Li Y; Guo Y; Cao Y; Li P; Wang Z; Gong Y; Ran H
Int J Nanomedicine; 2018; 13():5139-5158. PubMed ID: 30233177
[TBL] [Abstract][Full Text] [Related]
33. Folate receptor-targeted multimodal polymersomes for delivery of quantum dots and doxorubicin to breast adenocarcinoma: In vitro and in vivo evaluation.
Alibolandi M; Abnous K; Sadeghi F; Hosseinkhani H; Ramezani M; Hadizadeh F
Int J Pharm; 2016 Mar; 500(1-2):162-78. PubMed ID: 26802496
[TBL] [Abstract][Full Text] [Related]
34. Dual anticancer drug/superparamagnetic iron oxide-loaded PLGA-based nanoparticles for cancer therapy and magnetic resonance imaging.
Schleich N; Sibret P; Danhier P; Ucakar B; Laurent S; Muller RN; Jérôme C; Gallez B; Préat V; Danhier F
Int J Pharm; 2013 Apr; 447(1-2):94-101. PubMed ID: 23485340
[TBL] [Abstract][Full Text] [Related]
35. Folic acid-functionalized polyethylenimine superparamagnetic iron oxide nanoparticles as theranostic agents for magnetic resonance imaging and PD-L1 siRNA delivery for gastric cancer.
Luo X; Peng X; Hou J; Wu S; Shen J; Wang L
Int J Nanomedicine; 2017; 12():5331-5343. PubMed ID: 28794626
[TBL] [Abstract][Full Text] [Related]
36. pH-sensitive Au-BSA-DOX-FA nanocomposites for combined CT imaging and targeted drug delivery.
Huang H; Yang DP; Liu M; Wang X; Zhang Z; Zhou G; Liu W; Cao Y; Zhang WJ; Wang X
Int J Nanomedicine; 2017; 12():2829-2843. PubMed ID: 28435261
[TBL] [Abstract][Full Text] [Related]
37. The theranostic efficiency of tumor-specific, pH-responsive, peptide-modified, liposome-containing paclitaxel and superparamagnetic iron oxide nanoparticles.
Zheng XC; Ren W; Zhang S; Zhong T; Duan XC; Yin YF; Xu MQ; Hao YL; Li ZT; Li H; Liu M; Li ZY; Zhang X
Int J Nanomedicine; 2018; 13():1495-1504. PubMed ID: 29559778
[TBL] [Abstract][Full Text] [Related]
38. Multifunctional Dendrimer-Entrapped Gold Nanoparticles Conjugated with Doxorubicin for pH-Responsive Drug Delivery and Targeted Computed Tomography Imaging.
Zhu J; Wang G; Alves CS; Tomás H; Xiong Z; Shen M; Rodrigues J; Shi X
Langmuir; 2018 Oct; 34(41):12428-12435. PubMed ID: 30251859
[TBL] [Abstract][Full Text] [Related]
39. Multifunctional nanosheets based on folic acid modified manganese oxide for tumor-targeting theranostic application.
Hao Y; Wang L; Zhang B; Zhao H; Niu M; Hu Y; Zheng C; Zhang H; Chang J; Zhang Z; Zhang Y
Nanotechnology; 2016 Jan; 27(2):025101. PubMed ID: 26629735
[TBL] [Abstract][Full Text] [Related]
40. Folate-targeting magnetic core-shell nanocarriers for selective drug release and imaging.
Wang H; Wang S; Liao Z; Zhao P; Su W; Niu R; Chang J
Int J Pharm; 2012 Jul; 430(1-2):342-9. PubMed ID: 22525087
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]